Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Sleep Medicine ClinicsAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- A hundred years of narcolepsy research.Arch Ital Biol. 2001; 139: 207-220
- Narcolepsy with cataplexy.Lancet. 2007; 369: 499-511
- The clinical spectrum of narcolepsy with cataplexy: a reappraisal.J Sleep Res. 2004; 13: 395-406
- Hypothalamus, hypocretins/orexin, and vigilance control.Handb Clin Neurol. 2011; 99: 765-782
- Health-related quality of life in patients with narcolepsy.Sleep Med. 2007; 8: 733-741
- A 5-year prospective cohort study on health-related quality of life in patients with narcolepsy.Sleep Med. 2011; 12: 19-23
- Eigenthümliche mit Einschlafen verbundene Anfälle.Arch Psychiatr Nervenkr. 1877; 7: 631-635
- De la narcolepsie.Gaz Hôp (Paris). 1880; 53: 626-628
- Narcolepsy: clinical features, new pathophysiologic insights, and future perspectives.J Clin Neurophysiol. 2001; 18: 78-105
- Criteria for the diagnosis of the narcoleptic syndrome.Proc Staff Meet Mayo Clin. 1957; 32: 320-328
- Hypocretin deficiency in narcoleptic humans is associated with abdominal obesity.Obes Res. 2003; 11: 1147-1154
- Anxiety and mood disorders in narcolepsy: a case-control study.Gen Hosp Psychiatry. 2010; 32: 49-56
- High prevalence of eating disorders in narcolepsy with cataplexy: a case-control study.Sleep. 2008; 31: 335-341
- The epidemiology of narcolepsy.Sleep. 2007; 30: 13-26
- Prevalence of narcolepsy symptomatology and diagnosis in the European general population.Neurology. 2002; 58: 1826-1833
- The prevalence of narcolepsy: an epidemiological study of the Finnish twin cohort.Ann Neurol. 1994; 35: 709-716
- Narcolepsy is a rare disease in Israel.Sleep. 1987; 10: 608-609
- Census of narcolepsy, cataplexy and sleep life among teenagers in Fujisawa city.Sleep Res. 1979; 8: 191
- The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study.Sleep. 2002; 25: 197-202
- Factors associated with a delay in the diagnosis of narcolepsy.Sleep Med. 2004; 5: 37-41
- Age at onset of narcolepsy in two large populations of patients in France and Quebec.Neurology. 2001; 57: 2029-2033
- Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.Brain. 2011; 134: 3480-3492
- How age influences the expression of narcolepsy.J Psychosom Res. 2005; 59: 399-405
- Narcolepsy-cataplexy in a female dog.Exp Neurol. 1974; 45: 332-340
- Genetic factors in canine narcolepsy.Sleep. 1979; 1: 413-421
- The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.Cell. 1999; 98: 365-376
- Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation.Cell. 1999; 98: 437-451
- Pharmacological aspects of human and canine narcolepsy.Prog Neurobiol. 1997; 52: 27-78
- Aspects of the narcolepsy-cataplexy syndrome in O/E3-null mutant mice.Neuroscience. 2011; 183: 134-143
- Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat.J Neurosci. 2001; 21: 7273-7283
- Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep.J Neurosci. 2011; 31: 6518-6526
- Distinct narcolepsy syndromes in orexin receptor-2 and orexin null mice: molecular genetic dissection of non-REM and REM sleep regulatory processes.Neuron. 2003; 38: 715-730
- Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.Neuron. 2001; 30: 345-354
- A consensus definition of cataplexy in mouse models of narcolepsy.Sleep. 2009; 32: 111-116
- Hypocretin (orexin) deficiency in human narcolepsy.Lancet. 2000; 355: 39-40
- Low cerebrospinal fluid hypocretin (orexin) and altered energy homeostasis in human narcolepsy.Ann Neurol. 2001; 50: 381-388
- The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).Sleep Med. 2003; 4: 7-12
- CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.J Sleep Res. 2002; 11: 91-93
- Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.Sleep. 2002; 25: 733-736
- The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias.Arch Neurol. 2002; 59: 1553-1562
- CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.Neurology. 2001; 57: 2253-2258
- Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.Sleep Med Rev. 2005; 9: 269-310
- Hypocretin-1 (orexin A) deficiency in acute traumatic brain injury.Neurology. 2005; 65: 147-149
- Hypocretin-1 (orexin-A) concentrations in cerebrospinal fluid are low in patients with Guillain-Barre syndrome.Psychiatry Clin Neurosci. 2002; 56: 273-274
- CSF hypocretin levels in Guillain-Barre syndrome and other inflammatory neuropathies.Neurology. 2003; 61: 823-825
- Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.Neurology. 2004; 62: 138-140
- A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.Nat Med. 2000; 6: 991-997
- Reduced number of hypocretin neurons in human narcolepsy.Neuron. 2000; 27: 469-474
- Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.Brain Pathol. 2003; 13: 340-351
- Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.Neurology. 2005; 65: 1189-1192
- Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.Neurology. 2005; 65: 1184-1188
- The genetics of narcolepsy.Annu Rev Genomics Hum Genet. 2003; 4: 459-483
- Genetic and familial aspects of narcolepsy.Neurology. 1998; 50: S16-S22
- A monozygotic twin pair discordant for narcolepsy and CSF hypocretin-1.Neurology. 2004; 62: 2137-2138
- Monozygotic twins incompletely concordant for narcolepsy.Biol Psychiatry. 2001; 49: 943-947
- Monozygotic twins concordant for narcolepsy-cataplexy without any detectable abnormality in the hypocretin (orexin) pathway.Lancet. 2004; 363: 1199-1200
- Twin studies in narcolepsy.Sleep. 1994; 17: S13-S16
- HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive.Tissue Antigens. 1984; 24: 316-319
- HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.Sleep. 1997; 20: 1012-1020
- Extensive HLA class II studies in 58 non-DRB1*15 (DR2) narcoleptic patients with cataplexy.Tissue Antigens. 1997; 49: 329-341
- Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy.Nat Genet. 2010; 42: 786-789
- Narcolepsy is strongly associated with the T-cell receptor alpha locus.Nat Genet. 2009; 41: 708-711
- Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy.Tissue Antigens. 1999; 54: 138-145
- Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy.Tissue Antigens. 2000; 56: 446-448
- Common variants in P2RY11 are associated with narcolepsy.Nat Genet. 2011; 43: 66-71
- Narcolepsy: immunological aspects.Sleep Med Rev. 2008; 12: 95-107
- Narcolepsy: autoimmunity, effector T cell activation due to infection, or T cell independent, major histocompatibility complex class II induced neuronal loss?.Brain. 2010; 133: 1300-1311
- The frustrating and mostly fruitless search for an autoimmune cause of narcolepsy.Sleep. 2006; 29: 601-602
- Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.J Neuroimmunol. 2006; 174: 187-191
- Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602.Sleep. 2002; 25: 719-723
- Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy.Biol Psychiatry. 2005; 58: 504-509
- HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract.Sleep. 2005; 28: 1191-1192
- Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.J Clin Invest. 2010; 120: 713-719
- Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy.Sleep. 2010; 33: 869-874
- Anti-Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy.Sleep. 2010; 33: 875-878
- Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset.Sleep. 2009; 32: 979-983
- Narcolepsy and streptococcal infections.Sleep. 2009; 32: 1548
- Follow-up of four narcolepsy patients treated with intravenous immunoglobulins.Ann Neurol. 2006; 60: 153
- Successful management of cataplexy with intravenous immunoglobulins at narcolepsy onset.Ann Neurol. 2004; 56: 905-908
- Clinical efficacy of high-dose intravenous immunoglobulins near the onset of narcolepsy in a 10-year-old boy.J Sleep Res. 2003; 12: 347-348
- Response to intravenous immunoglobulins and placebo in a patient with narcolepsy with cataplexy.J Neurol. 2007; 254: 1607-1608
- Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy.J Neurol. 2008; 255: 1549-1554
- No persistent effect of intravenous immunoglobulins in patients with narcolepsy with cataplexy.J Neurol. 2008; 255: 1900-1903
- Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden.BMJ. 2011; 343: d5956
- Post-H1N1 narcolepsy-cataplexy.Sleep. 2010; 33: 1428-1430
- WHO backs further probes into possible link between H1N1 vaccine and narcolepsy in children.BMJ. 2011; 342: d909
- Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China.Ann Neurol. 2011; 70: 410-417
- Orexins (hypocretins) directly excite tuberomammillary neurons.Eur J Neurosci. 2001; 14: 1571-1575
- Neurons containing hypocretin (orexin) project to multiple neuronal systems.J Neurosci. 1998; 18: 9996-10015
- The sleep switch: hypothalamic control of sleep and wakefulness.Trends Neurosci. 2001; 24: 726-731
- Abnormal sleep/wake dynamics in orexin knockout mice.Sleep. 2010; 33: 297-306
- Behavioral state instability in orexin knock-out mice.J Neurosci. 2004; 24: 6291-6300
- Ambulatory 24 hour sleep-wake monitoring in narcolepsy-cataplexy compared to matched controls.Electroencephalogr Clin Neurophysiol. 1988; 70: 473-481
- Effects of startle and laughter in cataplectic subjects: a neurophysiological study between attacks.Clin Neurophysiol. 2000; 111: 1276-1281
- Weak with laughter.Lancet. 1999; 354: 838
- Corticospinal excitability during laughter: implications for cataplexy and the comparison with REM sleep atonia.J Sleep Res. 2004; 13: 257-264
- Cataplexy: ‘tonic immobility’ rather than 'REM-sleep atonia'?.Sleep Med. 2002; 3: 471-477
- Behavioral correlates of activity in identified hypocretin/orexin neurons.Neuron. 2005; 46: 787-798
- Physiology of REM sleep, cataplexy, and sleep paralysis.Adv Neurol. 1995; 67: 245-271
- Evidence for metabolic hypothalamo-amygdala dysfunction in narcolepsy.Sleep. 2009; 32: 607-613
- Abnormal activity in hypothalamus and amygdala during humour processing in human narcolepsy with cataplexy.Brain. 2008; 131: 514-522
- Nocturnal aspects of narcolepsy with cataplexy.Sleep Med Rev. 2008; 12: 109-128
- Scheduled naps in the management of daytime sleepiness in narcolepsy-cataplexy.Sleep. 1993; 16: 444-456
- The International Classification of Sleep Disorders: diagnostic and coding manual.2nd edition. AASM, Chicago2005
- Validation of a cataplexy questionnaire in 983 sleep-disorders patients.Sleep. 1999; 22: 77-87
- Clinical aspects and features of cataplexy.Adv Neurol. 1995; 67: 65-77
- The clinical features of cataplexy: a questionnaire study in narcolepsy patients with and without hypocretin-1 deficiency.Sleep Med. 2011; 12: 12-18
- Stability of cataplexy over several months–information for the design of therapeutic trials.Sleep. 1994; 17: 265-273
- Unusually prolonged rebound cataplexy after withdrawal of fluoxetine.Neurology. 2005; 65: 967-968
- Cataplexy features in childhood narcolepsy.Mov Disord. 2008; 23: 858-865
- Childhood narcolepsy with partial facial cataplexy: a diagnostic dilemma.Sleep Med. 2009; 10: 797-798
- Clinical, polysomnographic and laboratory characteristics of narcolepsy-cataplexy in a sample of children and adolescents.Sleep Med. 2011; 12: 24-27
- Psychotic symptoms in narcolepsy: phenomenology and a comparison with schizophrenia.Gen Hosp Psychiatry. 2009; 31: 146-154
- Florid refractory schizophrenias that turn out to be treatable variants of HLA-associated narcolepsy.J Nerv Ment Dis. 1991; 179 ([discussion: 8]): 12-17
- Twenty-four-hour recording in REM-narcoleptics with special reference to nocturnal sleep disruption.Biol Psychiatry. 1978; 13: 73-89
- Nocturnal sleep of narcoleptic patients: revisited.Sleep. 1986; 9: 159-161
- Night sleep does not predict day sleep in narcolepsy.Electroencephalogr Clin Neurophysiol. 1994; 91: 67-70
- The association between narcolepsy and REM behavior disorder (RBD).Sleep Med. 2005; 6: 253-258
- Motor dyscontrol in narcolepsy: rapid-eye-movement (REM) sleep without atonia and REM sleep behavior disorder.Ann Neurol. 1992; 32: 3-10
- Focusing on vigilance instead of sleepiness in the assessment of narcolepsy: high sensitivity of the Sustained Attention to Response Task (SART).Sleep. 2006; 29: 187-191
- Does memory impairment exist in narcolepsy-cataplexy?.J Clin Exp Neuropsychol. 1985; 7: 14-24
- Narcolepsy.Medicine. 1934; 13: 1-122
- Increased prevalence of obesity in narcoleptic patients and relatives.Eur Arch Psychiatry Clin Neurosci. 2001; 251: 85-89
- Increased body-mass index in patients with narcolepsy.Lancet. 2000; 355: 1274-1275
- Spontaneous food choice in narcolepsy.Sleep. 1996; 19: 75-76
- CSF versus serum leptin in narcolepsy: is there an effect of hypocretin deficiency?.Sleep. 2006; 29: 1017-1024
- Peripheral leptin levels in narcoleptic patients.Diabetes Technol Ther. 2007; 9: 348-353
- Reduction of plasma leptin levels and loss of its circadian rhythmicity in hypocretin (orexin)-deficient narcoleptic humans.J Clin Endocrinol Metab. 2002; 87: 805-809
- Somatotropic axis in hypocretin-deficient narcoleptic humans: altered circadian distribution of GH-secretory events.Am J Physiol Endocrinol Metab. 2003; 284: E641-E647
- Reduced leptin levels in human narcolepsy.Neuroendocrinology. 2000; 72: 195-198
- Psychological health in central hypersomnias: the French Harmony study.J Neurol Neurosurg Psychiatry. 2009; 80: 636-641
- Narcolepsy-cataplexy. II. Psychosocial consequences and associated psychopathology.Arch Neurol. 1982; 39: 169-171
- Narcolepsy and psychopathology: is there an association?.Sleep Med. 2002; 3: 353-360
- Reduced amygdala activity during aversive conditioning in human narcolepsy.Ann Neurol. 2010; 67: 394-398
- Severe fatigue in narcolepsy with cataplexy.J Sleep Res. 2012; 21: 163-169
- Validation of the fatigue severity scale in a Swiss cohort.Sleep. 2008; 31: 1601-1607
- Eating disorder and metabolism in narcoleptic patients.Sleep. 2007; 30: 1267-1273
- Weak with sex: sexual intercourse as a trigger for cataplexy.J Sex Med. 2009; 6: 2271-2277
- Psychosocial impact of narcolepsy.Sleep. 1994; 17: S45-S49
- Narcolepsy in New Zealand: pathway to diagnosis and effect on quality of life.N Z Med J. 2011; 124: 51-61
- Health-related quality of life in Portuguese patients with narcolepsy.Sleep Med. 2012; 13: 273-277
- Health-related quality of life in narcolepsy.Acta Neurol Scand. 2006; 114: 198-204
- Health-related quality of life in Italian patients with narcolepsy: the SF-36 health survey.Sleep Med. 2004; 5: 467-475
- Comparison of the psychosocial effects of epilepsy and narcolepsy/cataplexy: a controlled study.Epilepsia. 1984; 25: 423-433
- Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test.Sleep. 2005; 28: 113-121
- The multiple sleep latency test: a paradoxical test?.Clin Neurol Neurosurg. 1992; 94: S108-S110
- Value of the multiple sleep latency test (MSLT) for the diagnosis of narcolepsy.Sleep. 1997; 20: 620-629
- The frequency of multiple sleep onset REM periods among subjects with no excessive daytime sleepiness.Sleep. 1996; 19: 727-730
- CSF hypocretin-1 (orexin-A) levels in childhood narcolepsy and neurologic disorders.Neurology. 2004; 63: 2440-2442
- Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.J Clin Sleep Med. 2011; 7: 653-658
- Decreased cerebrospinal fluid hypocretin-1 levels near the onset of narcolepsy in 2 prepubertal children.Sleep. 2003; 26: 555-557
- Undetectable levels of CSF hypocretin-1 (orexin-A) in two prepubertal boys with narcolepsy.Neuropediatrics. 2002; 33: 51-52
- Hypocretins (orexins) and sleep-wake disorders.Lancet Neurol. 2005; 4: 673-682
- Guidelines for the appropriate use of CSF measurements to diagnose narcolepsy.in: Bassetti C. Billiard M. Mignot E. Narcolepsy and Hypersomnia. Informa Health Care, New York2007: 663-671
- Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.Sleep Med. 2009; 10: 1146-1150
- The role and validity of actigraphy in sleep medicine: an update.Sleep Med Rev. 2011; 15: 259-267
- The clinical spectrum of narcolepsy and idiopathic hypersomnia.Neurology. 1996; 46: 393-401
- Diagnosing narcolepsy: validity and reliability of new diagnostic criteria.Sleep Med. 2002; 3: 109-113
Article info
Footnotes
Financial support: Sebastiaan Overeem is supported by a VIDI grant from the Netherlands Organization for Scientific Research (grant number 016.116.371).
Financial disclosures/conflicts of interest: The authors have nothing to disclose.
Identification
Copyright
© 2012 Elsevier Inc. Published by Elsevier Inc. All rights reserved.
